Autologous Fat Grafting (AFG): A Systematic Review to Evaluate Oncological Safety in Breast Cancer Patients

Author:

Lo Torto Federico1,Patanè Luca1ORCID,Abbaticchio Donato1,Pagnotta Alessia2ORCID,Ribuffo Diego1

Affiliation:

1. Plastic Surgery Unit, Department of Surgery, Sapienza University of Rome, 00185 Rome, Italy

2. Hand and Microsurgery Unit of the Jewish Hospital of Rome, 00186 Rome, Italy

Abstract

Background: Autologous fat grafting (AFG) has emerged as a useful technique in breast reconstruction. Utilizing a patient’s own fat from areas like the abdomen or thighs, AFG serves various reconstruction needs. Nevertheless, the oncological safety of AFG in breast cancer patients has become a contentious issue. Concerns about its influence on cancer recurrence and detention have led to significant clinical debate and the need for thorough investigation. Methods: To determine the impact of autologous fat grafting (AFG) on loco-regional recurrence (LRR) in breast cancer survivors undergoing reconstruction, a comprehensive search of databases including PubMed, Medline, Web of Science, and Cochrane libraries was conducted from November 2023 through March 2024. This search adhered to the PRISMA guidelines and aimed to identify all the relevant studies on AFG in the context of breast reconstruction post cancer treatment. A meta-analysis was performed. Results: Out of the studies reviewed, 40 met the inclusion criteria, with a total patient cohort of 14,078. The analysis revealed that AFG had no significant association with increased rates of LRR. Conclusions: According to the available literature, AFG is a safe reconstructive option for breast cancer patients and does not increase the risk of loco-regional recurrence. Nevertheless, further well-structured long-term prospective studies are required, since heterogeneity of available studies is high and requires standardization.

Publisher

MDPI AG

Reference71 articles.

1. Breast cancer statistics, 2019;DeSantis;Cancer J. Clin.,2019

2. Surrogacy beyond prognosis: The importance of “trial-level” surrogacy;Buyse;Oncologist,2022

3. Landmark trials affecting the surgical management of invasive breast cancer;Black;Surg. Clin. N. Am.,2013

4. Oncoplastic conservative surgery for breast cancer: Long-term outcomes of our first ten years experience;Calabrese;Eur. Rev. Med. Pharmacol. Sci.,2018

5. Long-term Quality of Life in Patients with Breast Cancer after Breast Conservation vs. Mastectomy and Reconstruction;Hanson;JAMA Surg.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3